Stabilizing Group Treatment of Complex Trauma: A Randomized Controlled Trial
STAB
1 other identifier
interventional
158
1 country
1
Brief Summary
The research project outlined in this proposal aims to investigate the effectiveness of stabilizing group treatment as an add-on to conventional treatment, for patients with Post Traumatic Stress Disorder (PTSD) or dissociative disorders after childhood abuse. The investigators also aim to study psychophysiological markers associated with complex trauma and treatment, mechanisms of change involved in treatment, and which patient characteristics that predict positive outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 13, 2015
CompletedFirst Posted
Study publicly available on registry
May 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedSeptember 27, 2019
September 1, 2019
5.3 years
May 13, 2015
September 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Global Assessment of Functioning - change from baseline
Daily life functioning and severity of symptoms last week, assessed by interview
1 week after completed treatment
Global Assessment of Functioning- change from baseline
Daily life functioning and severity of symptoms last week, assessed by interview
6 months after completed treatment
Secondary Outcomes (14)
Heart rate variability- change from baseline
1 week after completed treatment
Heart rate variability - change from baseline
6 months after completed treatment
PTSD Symptom Scale - Self-Report - change from baseline
1 week after completed treatment
PTSD Symptom Scale - Self-Report - change from baseline
6 months after completed treatment
Symptom Checklist 90 Revised - change from baseline
1 week after completed treatment
- +9 more secondary outcomes
Other Outcomes (1)
Use of health services - change from 6 months pre-treatment
6 months after completed treatment
Study Arms (4)
Stabilizing group treatment for PTSD
EXPERIMENTALGroup treatment, 20 sessions psychoeducation and skills-training. In combination with conventional individual treatment.
Conventional Individual treatment - PTSD
ACTIVE COMPARATORConventional individual treatment.
Stabilizing group treatment for Dissociative disorders
EXPERIMENTALGroup treatment, 20 sessions psychoeducation and skills-training. In combination with conventional individual treatment.
Conventional Individual treatment - Dissociative disorders
ACTIVE COMPARATORConventional individual treatment.
Interventions
Individual psychotherapeutic treatment and case-management delivered by public outpatient clinics or private practicing psychologist/psychiatrist
20 sessions group psychotherapy for patients with PTSD, focused on psychoeducation and skills-training.
20 sessions group psychotherapy for patients with PTSD, focused on psychoeducation and skills-training
Eligibility Criteria
You may qualify if:
- participants must report a history of childhood abuse
- be between 18 and 65 years of age
- have enough competence in Norwegian to be able to participate in a psychoeducational group.
- In the PTSD arm of the study patients must meet the criteria for a DSM - 5 diagnosis of Posttraumatic Stress Disorder.
- In the Dissociative-disorders arm of the study the patients must meet criteria for a DSM-5 diagnosis of Dissociative Identity Disorder (DID) or Dissociative Disorder Not Otherwise Specified (DDNOS).
You may not qualify if:
- Acute suicidality
- Serious substance abuse interfering with treatment
- Serious psychotic symptoms
- Current life - crisis interfering with therapy (e.g. ongoing abuse, divorce, court case, somatic disease in spouse or children, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Modum Badlead
Study Sites (1)
Traumepoliklinikken, Modum Bad i Oslo
Oslo, 0259, Norway
Related Publications (1)
Baekkelund H, Ulvenes P, Boon-Langelaan S, Arnevik EA. Group treatment for complex dissociative disorders: a randomized clinical trial. BMC Psychiatry. 2022 May 16;22(1):338. doi: 10.1186/s12888-022-03970-8.
PMID: 35578194DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2015
First Posted
May 21, 2015
Study Start
June 1, 2014
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
September 27, 2019
Record last verified: 2019-09